Solvias is a world leader in contract research, development and manufacturing with headquarters in Kaiseraugst near Basel, Switzerland. Our highly qualified employees deliver unrivaled expertise, service and value to customers in the pharmaceutical, biotech, medical device and cosmetic industries.
Our laboratories operate to the highest standards and in accordance with ISO, GMP, GLP and FDA regulations. Drawing on a proven 20-year track record of scientific excellence, we provide integrated services to develop, analyze and test a wide range of biological and chemical substances, enabling our customers to bring safer and better products to the market faster.
Our laboratories operate to the highest standards and in accordance with ISO, GMP, GLP and FDA regulations. Drawing on a proven 20-year track record of scientific excellence, we provide integrated services to develop, analyze and test a wide range of biological and chemical substances, enabling our customers to bring safer and better products to the market faster.
Location: Switzerland, Aargau, Kaiseraugst
Employees: 501-1000
Founded date: 1999
Investors 2
| Date | Name | Website |
| - | BroadOak C... | broadoak.c... |
| - | Water Stre... | waterstree... |
Mentions in press and media 3
| Date | Title | Description |
| 24.09.2024 | Navigating Complexity: Tailoring Cell-Based Bioassays for Advanced Therapeutics, Upcoming Webinar Hosted by Xtalks | www.solvias.com In this free webinar, learn about the importance of cell-based bioassays (CBBAs) in drug development. Attendees will gain insights into the customization of CBBAs for complex therapeutics. The featured speakers will discuss ... |
| 05.03.2024 | Particulate Control in Pharmaceuticals: Safeguarding Products and Patients, Upcoming Webinar Hosted by Xtalks | www.solvias.com In this free webinar, navigate through a spectrum of cutting-edge technologies and tools that should be used for characterization, development and quality control. Attendees will explore the latest regulatory guidance for co... |
| 07.03.2023 | Geomega Announces $3M in Funding from Government of Canada’s Critical Minerals Research, Development and Demonstration Program | - |